Disease progression in Hutchinson-Gilford progeria syndrome: Impact on growth and development

Pediatrics

Volumn 120, Issue 4, 2007, Pages 824-833

  Gordon, Leslie B ^a,b,f   McCarten, Kathleen M ^a,b   Giobbie Hurder, Anita ^c   Machan, Jason T ^a   Campbell, Susan E ^d   Berns, Scott D ^a,b   Kieran, Mark W ^c,e  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BROWN UNIVERSITY   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f HASBRO CHILDREN'S HOSPITAL   (United States)

Author keywords

Clinical trial; Developmental dysplasia; Hutchinson Gilford progeria syndrome; Osteoporosis; Progeria

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; AVASCULAR NECROSIS; BODY WEIGHT; BONE; BONE DEMINERALIZATION; CHILD DEVELOPMENT; CLAVICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DIAPHYSIS; DISEASE COURSE; FEMALE; FEMUR; HUMAN; INFORMATION PROCESSING; MALE; MANDIBLE; MAXILLA; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PHENOTYPE; PREMATURE AGING; PRIORITY JOURNAL; PROGERIA; SCHOOL CHILD; SEX RATIO;

ADOLESCENT; BODY WEIGHT; BONE AND BONES; BONE DEMINERALIZATION, PATHOLOGIC; BONE DISEASES, DEVELOPMENTAL; BONE RESORPTION; CHILD; CHILD, PRESCHOOL; CONTRACTURE; DEVELOPMENTAL DISABILITIES; DISEASE PROGRESSION; FEMALE; FEMUR HEAD NECROSIS; HUMANS; INCISOR; INFANT; INFANT, NEWBORN; JOINT DISEASES; LONGITUDINAL STUDIES; MALE; PROGERIA; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TOOTH ERUPTION;

EID: 35148831133     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-1357     Document Type: Article

References (43)

1. Brown W, Zebrower M, Kieras F. Progeria, a model disease for the study of accelerated aging. Basic Life Sci. 1985;35:375-396
2. DeBusk FL. The Hutchinson-Gilford progeria syndrome. Report of 4 cases and review of the literature. J Pediatr. 1972;80:697-724
3. Hennekam RC. Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A. 2006;140:2603-2624
4. Cao H, Hegele RA. LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). J Hum Genet. 2003;48:271-274
5. De Sandre-Giovannoli A, Bernard R, Cau P, et al. Lamin a truncation in Hutchinson-Gilford progeria. Science. 2003;300:2055
6. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature. 2003;423:293-298
7. Goldman RD, Shumaker DK, Erdos MR, et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2004;101:8963-8968
8. Csoka AB, Cao H, Sammak PJ, Constantinescu D, Schatten GP, Hegele RA. Novel lamin A/C gene (LMNA) mutations in atypical progeroid syndromes. J Med Genet. 2004;41:304-308
9. Fernandez-Palazzi F, McLaren AT, Slowie DF. Report on a case of Hutchinson-Gilford progeria, with special reference to orthopedic problems. Eur J Pediatr Surg. 1992;2:378-382
10. Green LN. Progeria with carotid artery aneurysms: report of a case. Arch Neurol. 1981;38:659-661
11. Moen C. Orthopaedic aspects of progeria. J Bone Joint Surg Am. 1982;64:542-546
12. Gamble JG. Hip disease in Hutchinson-Gilford progeria syndrome. J Pediatr Orthop. 1984;4:585-589
13. Hasty MF, Vann J. Progeria in a pediatric dental patient: literature review and case report. Pediatr Dent. 1988;10:314-319
14. Reichel W, Bailey JA 2nd, Zigel S, Garcia-Bunuel R, Knox G. Radiological findings in progeria. J Am Geriatr Soc. 1971;19:657-674
15. Sood S, Rao RC, Ragav B, Berry M. Progeria syndrome with characteristic deformation of proximal radius observed on CT. Acta Radiol. 1991;32:67-68
16. Gupte S, Pal M, Sharma Y, Kohli U. Progeria with osteoarthritis in a four-year-old girl. A case report. Indian J Pediatr. 1976;43:319-320
17. Capell BC, Erdos MR, Madigan JP, et al. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2005;102:12879-12884
18. Fong LG, Frost D, Meta M, et al. A protein farnesyltransferase inhibitor ameliorates disease in a mouse model of progeria. Science. 2006;311:1621-1623
19. Glynn MW, Glover TW. Incomplete processing of mutant lamin A in Hutchinson-Gilford progeria leads to nuclear abnormalities, which are reversed by farnesyltransferase inhibition. Hum Mol Genet. 2005;14:2959-2969
20. Toth JI, Yang SH, Qiao X, et al. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc Natl Acad Sci U S A. 2005;102:12873-12878
21. Yang SH, Bergo MO, Toth JI, et al. Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. Proc Natl Acad Sci U S A. 2005;102:10291-10296
22. Yang SH, Meta M, Qiao X, et al. A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. J Clin Invest. 2006;116:2115-2121
23. Columbaro M, Capanni C, Mattioli E, et al. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. Cell Mol Life Sci. 2005;62:2669-2678
24. Huang S, Chen L, Libina N, et al. Correction of cellular phenotypes of Hutchinson-Gilford progeria cells by RNA interference. Hum Genet. 2005;118:444-450
25. Scaffidi P, Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med. 2005;11:440-445
26. Abdenur JE, Brown WT, Friedman S, Smith M, Lifshitz F. Response to nutritional and growth hormone treatment in progeria. Metabolism. 1997;46:851-856
27. Bridger JM, Kill IR. Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis. Exp Gerontol. 2004;39:717-724
28. Danes BS. Progeria: a cell culture study on aging. J Clin Invest. 1971;50:2000-2003
29. Goldstein S. Lifespan of cultured cells in progeria. Lancet. 1969;1(7591):424
30. Goldstein S. Studies on age-related diseases in cultured skin fibroblasts. J Invest Dermatol. 1979;73:19-23
31. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science. 2006;312:1059-1063
32. Hamer L, Kaplan F, Fallon M. The musculoskeletal manifestations of progeria: a literature review. Orthopedics. 1988;11:763-769
33. Llorens R. A review of osteoporosis: diagnosis and treatment. Mo Med. 2006;103:612-615; quiz 615-616
34. Resnick D. Diagnosis of Bone and Joint Disorders. 4th ed. Philadelphia, PA: WB Saunders; 2002
35. Rajzbaum G, Bezie Y. Postmenopausal osteoporosis and atheroma. Joint Bone Spine. 2006;73:661-666
36. Goldring S, Gravallese E. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol. 2000;12:195-199
37. Hall JW 3rd, Denneny JC 3rd. Audiologic and otolaryngologic findings in progeria: case report. J Am Acad Audiol. 1993;4:116-121
38. O'Meara W. Ectopic eruption pattern in selected permanent teeth. J Dent Res. 1962;41:607-616
39. Ash M, Nelson S. Wheeler's Dental Anatomy, Physiology and Occlusion. 7th ed. Philadelphia, PA: WB Saunders; 1993
40. Csoka AB, English SB, Simkevich CP, et al. Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell. 2004;3:235-243
41. Delahunt B, Stehbens WE, Gilbert-Barness E, Shozawa T, Ruger BM. Progeria kidney has abnormal mesangial collagen distribution. Pediatr Nephrol. 2000;15:279-285
42. Lemire JM, Patis C, Gordon LB, Sandy JD, Toole BP, Weiss AS. Aggrecan expression is substantially and abnormally upregulated in Hutchinson-Gilford progeria syndrome dermal fibroblasts. Mech Ageing Dev. 2006;127:660-669
43. Varga R, Eriksson M, Erdos MR, et al. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A. 2006;103:3250-3255